Search: id:"swepub:oai:research.chalmers.se:8c72d91c-d4b4-47f2-b0a6-b99883ae115f" >
Two statins and cro...
Two statins and cromolyn as possible drugs against the cytotoxicity of A beta(31-35) and A beta(25-35) peptides: a comparative study by advanced computer simulation methods
-
- Blomgren, Fredrik (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
- Rodin, Alexander (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
- Chrobak, Wojciech (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
show more...
-
- Pacut, Dawid Wojciech (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
- Swenson, Jan, 1966 (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
- Ermilova, Inna, 1983 (author)
- Chalmers tekniska högskola,Chalmers University of Technology
-
show less...
-
(creator_code:org_t)
- 2022
- 2022
- English.
-
In: RSC Advances. - : Royal Society of Chemistry (RSC). - 2046-2069. ; 12:21, s. 13352-13366
- Related links:
-
https://research.cha... (primary) (free)
-
show more...
-
https://research.cha...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- In this work, possible effective mechanisms of cromolyn, atorvastatin and lovastatin on the cytotoxicity of A beta(31-35) and A beta(25-35) peptides were investigated by classical molecular dynamics and well-tempered metadynamics simulations. The results demonstrate that all the drugs affect the behavior of the peptides, such as their ability to aggregate, and alter their secondary structures and their affinity to a particular drug. Our findings from the computed properties suggest that the best drug candidate is lovastatin. This medicine inhibits peptide aggregation, adsorbs the peptides on the surface of the drug clusters, changes the secondary structure and binds to MET35, which has been seen as the reason for the toxicity of the studied peptide sequences. Moreover, lovastatin is the drug which previously has demonstrated the strongest ability to penetrate the blood-brain barrier and makes lovastatin the most promising medicine among the three investigated drugs. Atorvastatin is also seen as a potential candidate if its penetration through the blood-brain barrier could be improved. Otherwise, its properties are even better than the ones demonstrated by lovastatin. Cromolyn appears to be less interesting as an anti-aggregant from the computational data, in comparison to the two statins.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmaceutiska vetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmaceutical Sciences (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
- NATURVETENSKAP -- Biologi -- Biofysik (hsv//swe)
- NATURAL SCIENCES -- Biological Sciences -- Biophysics (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
To the university's database